← Leaderboards
Jason Zhou
Zymeron Corporation
$1,599,986
Attributed
$1,599,986
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $700K · FY2020–22$1M$750K$500K$250K$0
'20
'21
'22
Funding mix
By agency
NIH$1,599,986 · 5
By mechanism
N43$1,299,986 · 4
N01$300,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Point Of Care Testing”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Mark Marino · Venturewell$53,810,465
- Bala Raja · Luminostics, Inc.$28,624,460
- Hanjoon Ryu$28,519,898
- Scott Fry$21,470,000
- Wally Narajowski$21,300,000
Research focus
Point Of Care TestingDiagnosticBloodSpecificityHepatitis C VirusHepatitis CInfectionPoint-Of-Care DiagnosticsSensitivity And SpecificityBacterial Drug ResistanceCohortClinically RelevantContractsCostAptamerAffinityBlood DonationsDiphosphatesDiagnostic TestsAnti-Retroviral AgentsElementsFreeze DryingHairDevices
Grant awards (5)
One Test, One Kit for Identifying Active Hepatitis C Virus (HCV) Infection at Home$400,000
N43 · FY2022 · CA · contact PI
POINT-OF-CARE (POC) DIAGNOSTICS FOR ANTIMICROBIAL RESISTANT PATHOGENS$300,000
N01 · FY2022 · AI · contact PI
RAPID POINT OF CARE TESTS FOR HEPATITIS C VIRUS$300,000
N43 · FY2021 · AI · contact PI
Rapid Point of Care Test to Quantify HIV Drugs for Adherence Monitoring$299,988
N43 · FY2021 · AI · contact PI
RAPID POINT OF CARE DIAGNOSTIC TEST FOR HISTOPLASMOSIS$299,998
N43 · FY2020 · AI · contact PI